Group 1 - Mingde Biological (002932.SZ) released its semi-annual report for 2025 on August 28, 2025, showing that as of August 27, 2025, 11 institutional investors held a total of 11.31 million shares, accounting for 4.86% of the total share capital [1] - The top ten institutional investors include major entities such as China Merchants Bank, Bank of China, and China Ping An Life Insurance, with their combined shareholding percentage decreasing by 2.23 percentage points compared to the previous quarter [1] Group 2 - In the public fund sector, three funds reported a decrease in holdings compared to the previous quarter, with a total reduction of 0.56% [2] - Four new public funds disclosed their holdings this quarter, including funds focused on dividend indices and medical devices [2] - In the insurance sector, one insurer, China Ping An Life Insurance, reported a slight decrease in holdings compared to the previous quarter [2]